Pacific Bio (PACB)
1.30
0.00 (0.00%)
Upcoming Events
Latest Headlines
UBS Assumes Pacific Biosciences of California (PACB) at Neutral
September 9, 2026 6:08 AM - StreetInsider
Form 4 PACIFIC BIOSCIENCES OF For: Aug 17 Filed by: Van Oene Mark
August 18, 2026 8:18 PM - SEC Filing
Form 144 PACIFIC BIOSCIENCES OF Filed by: Van Oene Mark
August 17, 2026 4:08 PM - SEC Filing
Form SCHEDULE 13G/A PACIFIC BIOSCIENCES OF Filed by: ARK Investment Management LLC
August 14, 2026 2:53 PM - SEC Filing
Form 4 PACIFIC BIOSCIENCES OF For: Aug 10 Filed by: Van Oene Mark
August 11, 2026 5:55 PM - SEC Filing
Form S-8 PACIFIC BIOSCIENCES OF
August 7, 2026 6:18 AM - SEC Filing
Form 10-Q PACIFIC BIOSCIENCES OF For: Jun 30
August 6, 2026 5:31 PM - SEC Filing
Form 8-K PACIFIC BIOSCIENCES OF For: Jul 30
August 5, 2026 4:27 PM - SEC Filing
Pacific Bio (PACB) Misses Q2 EPS by 1c
August 5, 2026 4:26 PM - StreetInsider
PacBio names Mark Van Oene as CEO, replacing Christian Henry
August 5, 2026 4:08 PM - StreetInsider
PacBio Appoints Mark Van Oene as President and Chief Executive Officer
August 5, 2026 4:08 PM - Globe NewsWire
PacBio Announces Second Quarter 2026 Financial Results
August 5, 2026 4:06 PM - Globe NewsWire
PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system
August 5, 2026 9:05 AM - Globe NewsWire
PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference
July 28, 2026 4:05 PM - Globe NewsWire
TD Cowen reports short interest changes in life science stocks
July 27, 2026 12:15 PM - StreetInsider
PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026
July 15, 2026 4:05 PM - Globe NewsWire
Form 8-K PACIFIC BIOSCIENCES OF For: Jul 08
July 9, 2026 4:33 PM - SEC Filing
Full Article List
